Studies are showing YES!
Psychedelics Research has been underway for over two decades, with newfound interest rapidly growing in recent years. In 2017 and 2018, the FDA approved the first clinical studies of two psychedelics in potential breakthrough therapies for PTSD and depression. Since then hundreds of studies have been launched with over 200 clinical studies currently underway at the time of this post.
According to MAPS founder, Rick Doblin, three macro doses of psychedelics with intensive psychotherapy before and after has shown the most effective results. This combination prepares study participants for the experience of the drug and also helps them to process what surfaces for them during their psychedelics sessions.
Want to be part of a Clinical Trial?
How To Join a Psychedelic Clinical Trial · Psychedelic Support – Search for studies or click on any drug manufacturer or educational institution for more information about their trials and studies.
You can also search for studies on clinicaltrials.gov.
More about Psychedelic Therapies and Psychedelic-assisted Psychotherapy:
- Could psychedelic drugs treat PTSD and depression? A Q&A with Rick Doblin | (ted.com)
- Psychedelics Research and Psilocybin Therapy – Johns Hopkins Psychedelics & Consciousness Research (hopkinsmedicine.org)
NIH case studies reviews: